Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
308,713,740
-
Total 13F shares
-
292,731,132
-
Share change
-
+16,249,075
-
Total reported value
-
$2,798,448,068
-
Put/Call ratio
-
69%
-
Price per share
-
$9.55
-
Number of holders
-
223
-
Value change
-
+$153,922,424
-
Number of buys
-
108
-
Number of sells
-
98
Institutional Holders of AMICUS THERAPEUTICS, INC. - Common Stock (FOLD) as of Q3 2021
As of 30 Sep 2021,
AMICUS THERAPEUTICS, INC. - Common Stock (FOLD) was held by
223 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
292,731,132 shares.
The largest 10 holders included
PERCEPTIVE ADVISORS LLC, VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, Redmile Group, LLC, BlackRock Inc., Avoro Capital Advisors LLC, JPMORGAN CHASE & CO, MORGAN STANLEY, Palo Alto Investors LP, and STATE STREET CORP.
This page lists
223
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.